Dr. Brian Robert Hinds, MD

Dr. Hinds practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Hinds' NPI, 1386969608, was assigned on March 30, 2010. Dr. Hinds graduated from Indiana University School Of Medicine in 2010. Dr. Hinds holds California license A130130.

Dr. Hinds' primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Hinds' primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Hinds is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Hinds to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hinds practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Hinds' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Hinds is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Hinds' licenses on file in 3 states: California, Idaho and Kentucky.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and joint cyst among the conditions Dr. Hinds treats.

CMS data shows 8,529 Medicare services from Dr. Hinds across 17 procedure codes in 2024, for 3,499 Medicare patients. Medicare paid $508,259 for them.

CMS counts 3,499 Medicare patients who saw Dr. Hinds in 2024. The largest group is 65 to 74, with 1,494 patients. 74% of them have high cholesterol, and 66% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hinds' median patient age at 61, with 53% women.

In 2024, Dr. Hinds wrote 758 Medicare Part D claims for 228 patients. 83% of them were for generic drugs. CMS names the drug for 631 of them, across 22 drugs with 11 or more claims each, at $561,535 in total drug cost. In 2023, CMS named 621 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hinds for performance year 2024, reported as part of a group. Dr. Hinds accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 613 procedures of removal of skin lesions by Dr. Hinds, more than 88% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 63 papers to Dr. Hinds, published from 2015 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Skin and Diagnosis, Differential. Dr. Hinds has published most often in JAAD Case Rep. Dr. Hinds' most frequent co-authors are Philip R. Cohen, MD, Amanda Fleming Marsch, MD and Richard L. Gallo, MD, PhD.

CMS Open Payments shows 5 general payments to Dr. Hinds from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $205.

Dr. Hinds graduated from Indiana University School Of Medicine in 2010.

Dr. Hinds is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.